Chances and Challenges of New Genetic Screening Technologies (NIPT) in Prenatal Medicine from a Clinical Perspective: A Narrative Review

In 1959, 63 years after the death of John Langdon Down, Jérôme Lejeune discovered trisomy 21 as the genetic reason for Down syndrome. Screening for Down syndrome has been applied since the 1960s by using maternal age as the risk parameter. Since then, several advances have been made. First trimester...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedei, Ivonne, Wolter, Aline, Weber, Axel, Signore, Fabrizio, Axt-Fliedner, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065512/
https://www.ncbi.nlm.nih.gov/pubmed/33805390
http://dx.doi.org/10.3390/genes12040501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065512/
https://www.ncbi.nlm.nih.gov/pubmed/33805390
http://dx.doi.org/10.3390/genes12040501

Ejemplares similares